It may therefore be posited that the administration of vitamin K (76), 1,25-dihydroxy-D3 (77) to patients exhibiting low osteocalcin levels may prove an efficacious method of reducing the risk of osteoporosis, particularly in those already diagnosed with the condition. Here, BGLAP is linked to osteoporosis.